| 000 | 01708 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515023252.0 | ||
| 264 | 0 | _c20060503 | |
| 008 | 200605s 0 0 eng d | ||
| 022 | _a1095-9203 | ||
| 024 | 7 |
_a10.1126/science.312.5772.380 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKaiser, Jocelyn | |
| 245 | 0 | 0 |
_aA one-size-fits-all flu vaccine? _h[electronic resource] |
| 260 |
_bScience (New York, N.Y.) _cApr 2006 |
||
| 300 |
_a380-2 p. _bdigital |
||
| 500 | _aPublication Type: News | ||
| 650 | 0 | 4 | _aAdjuvants, Immunologic |
| 650 | 0 | 4 | _aAdministration, Intranasal |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Viral _xbiosynthesis |
| 650 | 0 | 4 | _aAntigenic Variation |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 |
_aHemagglutinin Glycoproteins, Influenza Virus _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInfluenza A virus _ximmunology |
| 650 | 0 | 4 |
_aInfluenza Vaccines _xadministration & dosage |
| 650 | 0 | 4 |
_aInfluenza, Human _xprevention & control |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aNucleocapsid Proteins |
| 650 | 0 | 4 |
_aNucleoproteins _xgenetics |
| 650 | 0 | 4 |
_aOrthomyxoviridae Infections _xprevention & control |
| 650 | 0 | 4 |
_aRNA-Binding Proteins _xgenetics |
| 650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _ximmunology |
| 650 | 0 | 4 | _aVaccination |
| 650 | 0 | 4 |
_aVaccines, Attenuated _xadministration & dosage |
| 650 | 0 | 4 |
_aVaccines, DNA _xadministration & dosage |
| 650 | 0 | 4 |
_aViral Core Proteins _xgenetics |
| 650 | 0 | 4 |
_aViral Matrix Proteins _ximmunology |
| 773 | 0 |
_tScience (New York, N.Y.) _gvol. 312 _gno. 5772 _gp. 380-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1126/science.312.5772.380 _zAvailable from publisher's website |
| 999 |
_c16231877 _d16231877 |
||